Trial Profile
A Study to Evaluate the Efficacy and Safety of Combination of Everolimus and Tacrolimus With High Dosage of Mizoribine in Living Donor Kidney Transplant Recipients
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 10 Jun 2016
Price :
$35
*
At a glance
- Drugs Basiliximab (Primary) ; Everolimus (Primary) ; Mizoribine (Primary) ; Prednisolone (Primary) ; Tacrolimus (Primary)
- Indications Renal transplant rejection
- Focus Adverse reactions; Therapeutic Use
- 10 Jun 2016 New trial record